The phrase "accepted for clinical use" is correct and usable in written English.
It can be used when referring to a treatment, medication, or medical device that has been approved for use in clinical settings.
Example: "The new drug has been thoroughly tested and is now accepted for clinical use in treating the disease."
Alternatives: "approved for clinical application" or "authorized for clinical use".
Sagopilone is in active development phase and ixapebilone is accepted for clinical use in the treatment of breast cancer, and is also being clinically evaluated in the treatment of non-small cell lung cancer and prostate cancer (Liu et al, 2012; Smith, 2012).
However, owing to the biohazard associated with the use of viral vectors, viral gene therapy is not yet widely accepted for clinical use.
To date, few methods have been accepted for clinical use to set the appropriate PEEP.
In practice, a specific activity of 37 to 74 MBq (1 2 mCi) Lu per microgram of precursor is routinely achieved and is accepted for clinical use [ 66].
Before a new ACT protocol is accepted for clinical use, its efficacy has to be demonstrated in animal models, mainly in mice injected with tumor cell lines to simulate the disease.
Several prognostic factors are currently accepted for clinical use, such as nodal status and tumor stage; however, the disease status and clinicopathological conditions cannot unequivocally identify which patients are at low or high risk for disease recurrence [ 2, 6].
To date, however, no analytical technique has been widely accepted for clinical application.
To date, however, no analytical technique has been widely accepted for clinical application [ 22].
In human medicine, CEUS has already been accepted and recommended for clinical use in a variety of renal pathologies [ 1].
For instance, the Mini-Mental State Examination (MMSE) is one of the most widely used, and is accepted not only for clinical use but also for use in epidemiological surveys.
Drug-eluting stents were accepted for extensive clinical use based on randomized trials involving relatively few and selected patients, with angiographic follow-up data serving as the primary end point.
